Selected research
Market Structure
Global AI Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global AI Pharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for AI Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for AI Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of AI Pharmaceutical include Noetik, Atomwise, Cradle, Exscientia, Iktos, Insilico Medicine, BenevolentAI, Cyclica and Recursion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global AI Pharmaceutical market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Pharmaceutical and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Pharmaceutical revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Pharmaceutical market size, projected growth trends, production technologies, key applications, and end-use industries.
AI Pharmaceutical Segment by Company
Noetik
Atomwise
Cradle
Exscientia
Iktos
Insilico Medicine
BenevolentAI
Cyclica
Recursion
Auransa
InveniAI
Pfizer
IBM
AI Pharmaceutical Segment by Type
Artificial intelligence (AI)
Machine Learning (ML)
Others
AI Pharmaceutical Segment by Application
Drug Discovery
Clinical Trials
Others
AI Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Pharmaceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Pharmaceutical industry.
Chapter 3: Detailed analysis of AI Pharmaceutical companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Pharmaceuticalrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial intelligence (AI)
- Machine Learning (ML)
- Others
Applications
- Drug Discovery
- Clinical Trials
- Others
Companies covered
- Noetik
- Atomwise
- Cradle
- Exscientia
- Iktos
- Insilico Medicine
- BenevolentAI
- Cyclica
- Recursion
- Auransa
- InveniAI
- Pfizer
- IBM
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global AI Pharmaceutical Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Artificial intelligence (AI)
- 1.2.3 Machine Learning (ML)
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global AI Pharmaceutical Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Drug Discovery
- 1.3.3 Clinical Trials
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global AI Pharmaceutical Growth Trends by Region
- 1.5.1 Global AI Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 AI Pharmaceutical Market Size by Region (2021-2026)
- 1.5.3 AI Pharmaceutical Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global AI Pharmaceutical Market Dynamics
- 2.1 AI Pharmaceutical Industry Trends
- 2.2 AI Pharmaceutical Industry Drivers
- 2.3 AI Pharmaceutical Industry Opportunities and Challenges
- 2.4 AI Pharmaceutical Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global AI Pharmaceutical Revenue by Company (2021-2026)
- 3.2 Global AI Pharmaceutical Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global AI Pharmaceutical Key Company Head office and Area Served
- 3.4 Global AI Pharmaceutical Company, Product Type & Application
- 3.5 Global AI Pharmaceutical Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global AI Pharmaceutical Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 AI Pharmaceutical Players Market Share by Revenue in 2025
- 3.6.3 2025 AI Pharmaceutical Tier 1, Tier 2, and Tier 3
4 AI Pharmaceutical Market by Type
- 4.1 Global AI Pharmaceutical Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global AI Pharmaceutical Market Size by Type (2021-2032)
- 4.3 Global AI Pharmaceutical Market Size Share by Type (2021-2032)
5 AI Pharmaceutical Market by Application
- 5.1 Global AI Pharmaceutical Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global AI Pharmaceutical Market Size by Application (2021-2032)
- 5.3 Global AI Pharmaceutical Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Noetik
- 6.1.1 Noetik Company Information
- 6.1.2 Noetik Business Overview
- 6.1.3 Noetik AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Noetik AI Pharmaceutical Product Portfolio
- 6.1.5 Noetik Recent Developments
- 6.2 Atomwise
- 6.2.1 Atomwise Company Information
- 6.2.2 Atomwise Business Overview
- 6.2.3 Atomwise AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Atomwise AI Pharmaceutical Product Portfolio
- 6.2.5 Atomwise Recent Developments
- 6.3 Cradle
- 6.3.1 Cradle Company Information
- 6.3.2 Cradle Business Overview
- 6.3.3 Cradle AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Cradle AI Pharmaceutical Product Portfolio
- 6.3.5 Cradle Recent Developments
- 6.4 Exscientia
- 6.4.1 Exscientia Company Information
- 6.4.2 Exscientia Business Overview
- 6.4.3 Exscientia AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Exscientia AI Pharmaceutical Product Portfolio
- 6.4.5 Exscientia Recent Developments
- 6.5 Iktos
- 6.5.1 Iktos Company Information
- 6.5.2 Iktos Business Overview
- 6.5.3 Iktos AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Iktos AI Pharmaceutical Product Portfolio
- 6.5.5 Iktos Recent Developments
- 6.6 Insilico Medicine
- 6.6.1 Insilico Medicine Company Information
- 6.6.2 Insilico Medicine Business Overview
- 6.6.3 Insilico Medicine AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Insilico Medicine AI Pharmaceutical Product Portfolio
- 6.6.5 Insilico Medicine Recent Developments
- 6.7 BenevolentAI
- 6.7.1 BenevolentAI Company Information
- 6.7.2 BenevolentAI Business Overview
- 6.7.3 BenevolentAI AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 BenevolentAI AI Pharmaceutical Product Portfolio
- 6.7.5 BenevolentAI Recent Developments
- 6.8 Cyclica
- 6.8.1 Cyclica Company Information
- 6.8.2 Cyclica Business Overview
- 6.8.3 Cyclica AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Cyclica AI Pharmaceutical Product Portfolio
- 6.8.5 Cyclica Recent Developments
- 6.9 Recursion
- 6.9.1 Recursion Company Information
- 6.9.2 Recursion Business Overview
- 6.9.3 Recursion AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Recursion AI Pharmaceutical Product Portfolio
- 6.9.5 Recursion Recent Developments
- 6.10 Auransa
- 6.10.1 Auransa Company Information
- 6.10.2 Auransa Business Overview
- 6.10.3 Auransa AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Auransa AI Pharmaceutical Product Portfolio
- 6.10.5 Auransa Recent Developments
- 6.11 InveniAI
- 6.11.1 InveniAI Company Information
- 6.11.2 InveniAI Business Overview
- 6.11.3 InveniAI AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 InveniAI AI Pharmaceutical Product Portfolio
- 6.11.5 InveniAI Recent Developments
- 6.12 Pfizer
- 6.12.1 Pfizer Company Information
- 6.12.2 Pfizer Business Overview
- 6.12.3 Pfizer AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Pfizer AI Pharmaceutical Product Portfolio
- 6.12.5 Pfizer Recent Developments
- 6.13 IBM
- 6.13.1 IBM Company Information
- 6.13.2 IBM Business Overview
- 6.13.3 IBM AI Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 IBM AI Pharmaceutical Product Portfolio
- 6.13.5 IBM Recent Developments
7 North America
- 7.1 North America AI Pharmaceutical Market Size (2021-2032)
- 7.2 North America AI Pharmaceutical Market Size by Type
- 7.2.1 North America AI Pharmaceutical Market Size by Type (2021-2026)
- 7.2.2 North America AI Pharmaceutical Market Size by Type (2027-2032)
- 7.2.3 North America AI Pharmaceutical Market Share by Type (2021-2032)
- 7.3 North America AI Pharmaceutical Market Size by Application
- 7.3.1 North America AI Pharmaceutical Market Size by Application (2021-2026)
- 7.3.2 North America AI Pharmaceutical Market Size by Application (2027-2032)
- 7.3.3 North America AI Pharmaceutical Market Share by Application (2021-2032)
- 7.4 North America AI Pharmaceutical Market Size by Country
- 7.4.1 North America AI Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America AI Pharmaceutical Market Size by Country (2021-2026)
- 7.4.3 North America AI Pharmaceutical Market Size by Country (2027-2032)
- 7.4.4 North America AI Pharmaceutical Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe AI Pharmaceutical Market Size (2021-2032)
- 8.2 Europe AI Pharmaceutical Market Size by Type
- 8.2.1 Europe AI Pharmaceutical Market Size by Type (2021-2026)
- 8.2.2 Europe AI Pharmaceutical Market Size by Type (2027-2032)
- 8.2.3 Europe AI Pharmaceutical Market Share by Type (2021-2032)
- 8.3 Europe AI Pharmaceutical Market Size by Application
- 8.3.1 Europe AI Pharmaceutical Market Size by Application (2021-2026)
- 8.3.2 Europe AI Pharmaceutical Market Size by Application (2027-2032)
- 8.3.3 Europe AI Pharmaceutical Market Share by Application (2021-2032)
- 8.4 Europe AI Pharmaceutical Market Size by Country
- 8.4.1 Europe AI Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe AI Pharmaceutical Market Size by Country (2021-2026)
- 8.4.3 Europe AI Pharmaceutical Market Size by Country (2027-2032)
- 8.4.4 Europe AI Pharmaceutical Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China AI Pharmaceutical Market Size (2021-2032)
- 9.2 China AI Pharmaceutical Market Size by Type
- 9.2.1 China AI Pharmaceutical Market Size by Type (2021-2026)
- 9.2.2 China AI Pharmaceutical Market Size by Type (2027-2032)
- 9.2.3 China AI Pharmaceutical Market Share by Type (2021-2032)
- 9.3 China AI Pharmaceutical Market Size by Application
- 9.3.1 China AI Pharmaceutical Market Size by Application (2021-2026)
- 9.3.2 China AI Pharmaceutical Market Size by Application (2027-2032)
- 9.3.3 China AI Pharmaceutical Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia AI Pharmaceutical Market Size (2021-2032)
- 10.2 Asia AI Pharmaceutical Market Size by Type
- 10.2.1 Asia AI Pharmaceutical Market Size by Type (2021-2026)
- 10.2.2 Asia AI Pharmaceutical Market Size by Type (2027-2032)
- 10.2.3 Asia AI Pharmaceutical Market Share by Type (2021-2032)
- 10.3 Asia AI Pharmaceutical Market Size by Application
- 10.3.1 Asia AI Pharmaceutical Market Size by Application (2021-2026)
- 10.3.2 Asia AI Pharmaceutical Market Size by Application (2027-2032)
- 10.3.3 Asia AI Pharmaceutical Market Share by Application (2021-2032)
- 10.4 Asia AI Pharmaceutical Market Size by Country
- 10.4.1 Asia AI Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia AI Pharmaceutical Market Size by Country (2021-2026)
- 10.4.3 Asia AI Pharmaceutical Market Size by Country (2027-2032)
- 10.4.4 Asia AI Pharmaceutical Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa AI Pharmaceutical Market Size (2021-2032)
- 11.2 South America, Middle East & Africa AI Pharmaceutical Market Size by Type
- 11.2.1 South America, Middle East & Africa AI Pharmaceutical Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa AI Pharmaceutical Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa AI Pharmaceutical Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa AI Pharmaceutical Market Size by Application
- 11.3.1 South America, Middle East & Africa AI Pharmaceutical Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa AI Pharmaceutical Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa AI Pharmaceutical Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa AI Pharmaceutical Market Size by Country
- 11.4.1 South America, Middle East & Africa AI Pharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa AI Pharmaceutical Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa AI Pharmaceutical Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa AI Pharmaceutical Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst